Open AccessDual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?
Author(s) -
Hussein Farghaly,
Mohamed Sayed,
Hatem Nasr,
Ahmed Maklad
Publication year - 2015
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/0972-3919.159693
Subject(s) - medicine , nuclear medicine , positron emission tomography , fluorodeoxyglucose , standardized uptake value , lung cancer , lesion , magnetic resonance imaging , histopathology , radiology , lymphoma , cancer , pathology
Assess the added value of dual time point F-18-fluorodeoxyglucose positron emission tomography/computed tomography (DTP F-18-FDG-PET/CT) in the differentiation of malignant from a benign lesion in cancer patients.